BiO2 Medical, Inc.'s IDE Application for the Angel™ Catheter Receives FDA Approval
5/1/2013 7:26:11 AM
More...
|
UK Hospital is the First in Europe to Place BiO2 Medical, Inc.'s Combined Triple Lumen CVC/IVC Filter, Known as the Angel™ Catheter, in a Critically Ill Patient to Protect From Life-Threatening Pulmonary Embolism
3/12/2013 9:40:00 AM
More...
|
BiO2 Medical, Inc.'s Combined Triple Lumen/IVC Filter Marketed as the Angel™ Catheter Receives CE Mark
12/10/2012 7:28:26 AM
More...
|
BiO2 Medical, Inc. Raises $12 Million in Series C Funding
9/10/2012 7:04:43 AM
More...
|
BiO2 Medical, Inc. Granted CE Mark for the Angel™ Catheter, the First IVC Filter With a Prophylactic Use Indication
5/16/2012 6:43:18 AM
More...
|
BiO2 Medical, Inc. Announces First in Man Clinical Study
3/28/2012 10:21:58 AM
More...
|
BiO2 Medical, Inc. Raises $13.7 Million
3/26/2012 8:01:29 AM
More...
|
BiO2 Medical, Inc. Raises $4.6 Million
8/17/2011 9:18:52 AM
More...
|
Life-Saving Filter Technology BiO2 Medical, Inc. Attracts $7.5M From Local Investors
5/7/2010 8:54:19 AM
More...
|